Permanent J-Code for Epioxa - Summary - MDSpire
From the Journals

Permanent J-Code for Epioxa

Glaukos secures permanent J-code from CMS ahead of July rollout

  • April 22, 2026

  • 2 min

Share

Glaukos has secured a permanent HCPCS J-code (J2789) for its Epioxa therapy, which will simplify billing and reimbursement for its epithelium-on corneal cross-linking treatment for keratoconus, effective July 1, 2026. This milestone is expected to enhance payer acceptance and improve access for patients, as expressed by CEO Thomas Burns. The therapy aims to avoid epithelial removal, offering a less painful alternative and expediting recovery. Acknowledging its underdiagnosed status, Glaukos emphasizes the need for increased awareness and treatment of keratoconus.

Original Source(s)

Permanent J-Code for Epioxa

  • April 22, 2026

Related Content

Phacoemulsification Training in Rwanda

How an intensive phacoemulsification training program helped develop advanced ophthalmic procedures in the country

Ocular Surface Control: A Modern Approach to Peri-operative Dry Eye Management

Join us for a focused webinar exploring a modern approach to peri-operative dry eye management

  • April 22, 2026

Bigger Databases, Better Glaucoma Detection?

Expanding OCT reference databases could improve the consistency of diagnostic thresholds and reduce missed glaucoma cases, study finds

  • April 21, 2026

  • 3 min